Suppr超能文献

肾上腺素和去甲肾上腺素在注射液中的稳定性的虚构和事实。

Ficts and facts of epinephrine and norepinephrine stability in injectable solutions.

机构信息

University of Wuerzburg, Institute of Pharmacy and Food Chemistry, Wuerzburg, Germany.

出版信息

Int J Pharm. 2012 Sep 15;434(1-2):468-80. doi: 10.1016/j.ijpharm.2012.05.017. Epub 2012 May 18.

Abstract

Epinephrine (EPI) and norepinephrine (NE) play an important role in emergency medicine and acute treatment of hypotension and shocks in the intensive care unit. Injectable solutions can either be provided as proprietary medicinal products or as individually prepared dilutions. Due to the chemical structure of EPI and NE, the stability of the corresponding solutions is limited. Thus, most manufacturers of EPI and NE injectable solutions use sulfites and nitrogen for stabilization, Nevertheless, storage conditions such as temperature and light have to be considered, but are often neglected in the daily hospital routine. In addition, hospital pharmacies prepare EPI and NE solutions and dilute commercially available solutions for individual therapy, especially on ICUs. Since the influence of dilution and the presence of excipients and other preservatives are not systematically explored, we collected published data and investigations on stability on the potency of EPI and NE injectable solutions in order to deduce storage recommendations for diluted EPI and NE solutions of different concentration.

摘要

肾上腺素(EPI)和去甲肾上腺素(NE)在急诊医学和重症监护病房低血压和休克的急性治疗中起着重要作用。可注射溶液可以作为专有药物产品提供,也可以作为单独制备的稀释液提供。由于 EPI 和 NE 的化学结构,相应溶液的稳定性受到限制。因此,大多数 EPI 和 NE 注射用溶液的制造商使用亚硫酸盐和氮气来稳定,但必须考虑储存条件,如温度和光照,但在日常医院常规中经常被忽视。此外,医院药房会准备 EPI 和 NE 溶液,并为个体治疗稀释市售溶液,尤其是在 ICU 中。由于稀释和赋形剂及其他防腐剂的存在的影响没有得到系统的探索,我们收集了已发表的数据和关于 EPI 和 NE 注射用溶液效力稳定性的研究,以便推导出不同浓度稀释 EPI 和 NE 溶液的储存建议。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验